Literature DB >> 10448060

Evidence for the involvement of JAK/STAT pathway in the signaling mechanism of interleukin-17.

S V Subramaniam1, R S Cooper, S E Adunyah.   

Abstract

Interleukin-17 is a T-cell-derived pro-inflammatory cytokine, exhibiting multiple biological activities in a variety of cells and believed to fine tune all general phases of hematopoietic response. However, the signaling mechanism of this novel cytokine remains unknown. Here, we report for the first time that the early signaling events triggered by interleukin-17 involve tyrosine phosphorylation of several members of the JAK and STAT proteins in human U937 monocytic leukemia cells. Immunoprecipitation with specific antibodies followed by Western blot analysis with antiphosphotyrosine antibody has shown that in U937 cells, interleukin-17 induces time-dependent stimulation of tyrosine phosphorylation of JAK 1, 2 and 3, Tyk 2 and STAT 1, 2, 3 and 4 within 0.5 to 30 min. Interleukin-17-mediated tyrosine phosphorylation of these proteins strongly suggests that the JAK/STAT signaling pathway may play a major role in transducing signals from interleukin-17 receptors to the nucleus. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10448060     DOI: 10.1006/bbrc.1999.1156

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  31 in total

1.  New Approaches for Studying Alcoholic Liver Disease.

Authors:  Jun Xu; Xiao Liu; Bin Gao; Michael Karin; Hidekazu Tsukamoto; David Brenner; Tatiana Kisseleva
Journal:  Curr Pathobiol Rep       Date:  2014-09-14

Review 2.  Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy.

Authors:  Fang Shen; Sarah L Gaffen
Journal:  Cytokine       Date:  2008-01-04       Impact factor: 3.861

3.  STAT4 is required for antibacterial defense but enhances mortality during polymicrobial sepsis.

Authors:  C J Godshall; A B Lentsch; J C Peyton; M J Scott; W G Cheadle
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

4.  The role of IL-17 signaling in regulation of the liver-brain axis and intestinal permeability in Alcoholic Liver Disease.

Authors:  Hsiao-Yen Ma; Jun Xu; Xiao Liu; Yunheng Zhu; Bin Gao; Michael Karin; Hidekazu Tsukamoto; Dilip V Jeste; Igor Grant; Amanda J Roberts; Candice Contet; Cedric Geoffroy; Binhai Zheng; David Brenner; Tatiana Kisseleva
Journal:  Curr Pathobiol Rep       Date:  2016-02-19

5.  Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice.

Authors:  Fanli Meng; Kai Wang; Tomonori Aoyama; Sergei I Grivennikov; YongHan Paik; David Scholten; Min Cong; Keiko Iwaisako; Xiao Liu; Mingjun Zhang; Christoph H Österreicher; Felix Stickel; Klaus Ley; David A Brenner; Tatiana Kisseleva
Journal:  Gastroenterology       Date:  2012-06-08       Impact factor: 22.682

6.  The myeloid differentiation factor 88 (MyD88) is required for CD4+ T cell effector function in a murine model of inflammatory bowel disease.

Authors:  Masayuki Fukata; Keith Breglio; Anli Chen; Arunan S Vamadevan; Tyralee Goo; David Hsu; Daisy Conduah; Ruliang Xu; Maria T Abreu
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

7.  Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer.

Authors:  T Xiang; H Long; L He; X Han; K Lin; Z Liang; W Zhuo; R Xie; B Zhu
Journal:  Oncogene       Date:  2013-12-23       Impact factor: 9.867

8.  MOG(35-55) i.v suppresses experimental autoimmune encephalomyelitis partially through modulation of Th17 and JAK/STAT pathways.

Authors:  Zhilong Jiang; Hongmei Li; Denise C Fitzgerald; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Eur J Immunol       Date:  2009-03       Impact factor: 5.532

9.  Interleukin-6 (IL-6) and IL-17 synergistically promote viral persistence by inhibiting cellular apoptosis and cytotoxic T cell function.

Authors:  Wanqiu Hou; Young-Hee Jin; Hyun Seok Kang; Byung S Kim
Journal:  J Virol       Date:  2014-05-14       Impact factor: 5.103

10.  In vivo effects of interleukin-17 on haematopoietic cells and cytokine release in normal mice.

Authors:  G Jovcić; D Bugarski; M Petakov; A Krstić; M Vlaski; N Stojanović; P Milenković
Journal:  Cell Prolif       Date:  2004-12       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.